期刊文献+

细胞凋亡在结肠腺癌组织中的变化及其相关蛋白的表达 被引量:2

Apoptosis and expression of apoptosis-related proteins Bcl-2,Bcl-xL and Bcl-w in human colon adenocarcinoma
下载PDF
导出
摘要 目的:观察结肠腺癌组织细胞凋亡的变化,探讨抑制凋亡蛋白Bcl-2、Bcl-xL及Bcl-w在结肠腺癌中的作用.方法:收集14例我院手术切除结肠腺癌标本,肠镜取正常结肠黏膜组织27例,所有标本均经病理明确诊断.用TUNEL法检测其组织细胞凋亡水平,并用免疫组织化学PV法检测蛋白Bcl-2、Bcl-xL及Bcl-w的表达水平.结果:正常结肠黏膜组织的细胞凋亡指数明显高于结肠腺癌,有统计学显著性差异(t=3.35,P=0.002);结肠腺癌中Bcl-xL与Bcl-w的表达均高于正常结肠黏膜组织,有统计学差异(92.86%vs11.11%;85.71%vs0%,P<0.01或P<0.05);Bcl-2的表达与正常结肠黏膜组织没有统计学差异(P>0.05).结论:结肠腺癌的组织细胞凋亡明显低于正常结肠组织;结肠腺癌中抑制凋亡蛋白Bcl-xL与Bcl-w的高表达可能发挥了重要的作用. AIM: To examine the occurrence of apoptosis in colon adenocarcinoma and investigate the role of Bcl-2, Bcl-xL and Bcl-w as mediators of apoptosis.METHODS: Fourteen human colon adenocarcinoma specimens were obtained by surgical resection and pathologically confirmed. Twentyseven normal colon tissue specimens were obtained by colonoscopic biopsy. Apoptosis was detected using the terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay. The expression of Bcl-2, Bcl-xL and Bcl-w proteins was measured by immunohistochemistry.RESULTS: Compared with normal colon tis-sues, the apoptosis index (AI) in colon adenocarcinoma tissues significantly decreased (t = 3.35, P = 0.002). The expression levels of Bcl-xL and Bcl-w proteins were significantly higher in colon adenocarcinoma tissues than in normal colon tissues (92.86% vs 11.11% and 85.71% vs 0%, respectively; P 〈 0.01 and 0.05), whereas no significant difference was noted in the expression level of Bcl-2 protein between adenocarcinoma and normal colon tissues (P 〉 0.05).CONCLUSION: Apoptosis occurs in normal colon tissue but decreases in colon adenocarcinoma. Both Bcl-xL and Bcl-w proteins, rather than Bcl-2 protein, may play an important role in the suppression of apoptosis in colon adenocarcinoma.
出处 《世界华人消化杂志》 CAS 北大核心 2009年第25期2589-2594,共6页 World Chinese Journal of Digestology
基金 国家自然科学基金资助项目 No.30571810~~
关键词 结肠腺癌 BCL-2 BCL-XL BCL-W 凋亡 Colon adenocarcinoma Bcl-2 Bcl-xL Bcl-w Apoptosis
  • 相关文献

参考文献2

二级参考文献35

  • 1[1]Boyle P,Ferlay J.Cancer incidence and mortality in Europe,2004.Ann Oncol 2005; 16:481-488
  • 2[2]Gonen M,Hummer A,Zervoudakis A,Sullivan D,Fong Y,Banerjee D,Klimstra D,Cordon-Cardo C,Bertino J,Kemeny N.Thymidylate synthase expression in hepatic tumors is a predictor of survival and progression in patients with resectable metastatic colorectal cancer.J Clin Oncol 2003; 21:406-412
  • 3[3]Suda Y,Kuwashima Y,Tanaka Y,Uchida K,Akazawa S.Immunohistochemical detection of thymidylate synthase in advanced gastric cancer:a prognostic indicator in patients undergoing gastrectomy followed by adjuvant chemotherapy with 5-fluoropyrimidines.Anticancer Res 1999; 19:805-810
  • 4[4]Suzuki M,Tsukagoshi S,Saga Y,Ohwada M,Sato I.Enhanced expression of thymidylate synthase may be of prognostic importance in advanced cervical cancer.Oncology 1999; 57:50-54
  • 5[5]Bronner MP,Culin C,Reed JC,Furth EE.The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model.Am J Pathol 1995; 146:20-26
  • 6[6]Sinicrope FA,Ruan SB,Cleary KR,Stephens LC,Lee JJ,Levin B.bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis.Cancer Res 1995; 55:237-241
  • 7[7]Hockenbery D,Nunez G,Milliman C,Schreiber RD,Korsmeyer SJ.Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death.Nature 1990; 348:334-336
  • 8[8]Pidgeon GP,Barr MP,Harmey JH,Foley DA,BouchierHayes DJ.Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma ceils.Br J Cancer 2001; 85:273-278
  • 9[9]Gllmelius B,Ristamaki R,Kjaer M,Pfeiffer P,Skovsgaard T,Tveit KM,Linne T,Frodin JE,Boussard B,Oulid-Aessa D,Pyrhonen S.Irinotecan combined with bolus 5-fluorouracil and folinic acid Nordic schedule as first-line therapy in advanced colorectal cancer.Ann Oncol 2002; 13:1868-1873
  • 10[10]Peters GJ,van der Wilt CL,van Groeningen CJ,Smid K,Meijer S,Pinedo HM.Thymidylate synthase inhibition after administration of fluorouracil with or without leucovorin in colon cancer patients:implications for treatment with fluorouracil.J Clin Oncol 1994; 12:2035-2042

共引文献2

同被引文献22

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部